These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 25025286)

  • 21. In-stent restenosis: the gold standard has changed.
    Chin K
    EuroIntervention; 2011 May; 7 Suppl K():K43-6. PubMed ID: 22027726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model.
    Sharif F; Hynes SO; McCullagh KJ; Ganley S; Greiser U; McHugh P; Crowley J; Barry F; O'Brien T
    Gene Ther; 2012 Mar; 19(3):321-8. PubMed ID: 21716298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrical stimulation inhibits neointimal hyperplasia after abdominal aorta balloon injury through the PTEN/p27Kip1 pathway.
    Zhang P; Liu Z; He G; Liu J; Feng J
    Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):807-15. PubMed ID: 20929926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term rapamycin for inhibition of neointima formation after balloon-mediated aortic injury in rats: is there a window of opportunity for systemic prophylaxis of restenosis?
    Jahnke T; Schäfer FK; Bolte H; Heuer G; Karbe U; Brossmann J; Brandt M; Heller M; Müller-Hülsbeck S
    J Endovasc Ther; 2005 Jun; 12(3):332-42. PubMed ID: 15943508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh.
    Kohler TR; Toleikis PM; Gravett DM; Avelar RL
    J Vasc Surg; 2007 May; 45(5):1029-1037; discussion 1037-8. PubMed ID: 17466798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen-eluting stent implantation inhibits neointimal formation and extracellular signal-regulated kinase activation.
    Han Y; Liang M; Kang J; Qi Y; Deng J; Xu K; Yan C
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):647-53. PubMed ID: 17621663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of folate on neointima formation and matrix metalloproteinase-9 expression after balloon injury in hyperhomocysteinemic rabbits.
    Liu F; Zhang J; Yu S; Wang R; Wang B; Lai L; Yin H; Liu G
    Int J Cardiol; 2008 Dec; 131(1):59-65. PubMed ID: 18180053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of short-term intra-arterial delivery of paclitaxel on neointimal hyperplasia and the local thrombotic environment after angioplasty.
    E Y; He N; Fan H
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1086-96. PubMed ID: 23474915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
    Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
    Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
    Hirata Y; Kurobe H; Nishio C; Tanaka K; Fukuda D; Uematsu E; Nishimoto S; Soeki T; Harada N; Sakaue H; Kitagawa T; Shimabukuro M; Nakaya Y; Sata M
    Eur J Pharmacol; 2013 Jan; 699(1-3):106-11. PubMed ID: 23220706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of n-butylidenephthalide on neointimal hyperplasia in balloon injured rat carotid artery.
    Liu WS; Lin PC; Chang LF; Harn HJ; Shiuan D; Chiou TW; Jeng JR
    Phytother Res; 2011 Oct; 25(10):1494-502. PubMed ID: 21365711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Valsartan eluting-stents inhibited neointimal hyperplasia by decreasing collagen deposition in rabbits].
    Wang L; Jia SQ; Li GH; Chen H; Li HW; Zhao L; Yao DK; Ding RJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):450-3. PubMed ID: 16776965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant human SDF-1a on re-endothelialization after sirolimus-eluting stent implantation in rabbit aorta abdominalis.
    Zhang L; Zhu J; Du R; Zhu Z; Zhang J; Han W; Zhang R
    Life Sci; 2011 Dec; 89(25-26):926-30. PubMed ID: 21989205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?
    Schrepfer S; Deuse T; Sultan KR; Haddad M; Böger R; Münzel T; Schäfer H; Pelletier MP; Robbins RC; Reichenspurner H
    Cardiology; 2007; 108(2):128-37. PubMed ID: 17028423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stent restenosis: effect of drug type, release kinetics, hemodynamics and coating strategy.
    Papafaklis MI; Chatzizisis YS; Naka KK; Giannoglou GD; Michalis LK
    Pharmacol Ther; 2012 Apr; 134(1):43-53. PubMed ID: 22212618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits.
    Narita H; Chen S; Komori K; Kadomatsu K
    J Vasc Surg; 2008 Jun; 47(6):1322-9. PubMed ID: 18353604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury.
    Tian Z; Miyata K; Tazume H; Sakaguchi H; Kadomatsu T; Horio E; Takahashi O; Komohara Y; Araki K; Hirata Y; Tabata M; Takanashi S; Takeya M; Hao H; Shimabukuro M; Sata M; Kawasuji M; Oike Y
    J Mol Cell Cardiol; 2013 Apr; 57():1-12. PubMed ID: 23333801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
    Kleinedler JJ; Foley JD; Orchard EA; Dugas TR
    J Control Release; 2012 Apr; 159(1):27-33. PubMed ID: 22269665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.